Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Complex two-gene modulation of lung disease severity in children with cystic fibrosis.

Dorfman R, Sandford A, Taylor C, Huang B, Frangolias D, Wang Y, Sang R, Pereira L, Sun L, Berthiaume Y, Tsui LC, Paré PD, Durie P, Corey M, Zielenski J.

J Clin Invest. 2008 Mar;118(3):1040-9. doi: 10.1172/JCI33754.

2.

Mannose-binding lectin gene as a modifier of the cystic fibrosis phenotype in Argentinean pediatric patients.

Gravina LP, Crespo C, Giugno H, Sen L, Chertkoff L, Mangano A, Castaños C.

J Cyst Fibros. 2015 Jan;14(1):78-83. doi: 10.1016/j.jcf.2014.07.012. Epub 2014 Aug 29.

3.

Association of MBL2, TGF-beta1 and CD14 gene polymorphisms with lung disease severity in cystic fibrosis.

Faria EJ, Faria IC, Ribeiro JD, Ribeiro AF, Hessel G, Bertuzzo CS.

J Bras Pneumol. 2009 Apr;35(4):334-42. English, Portuguese.

4.

Use of a modeling framework to evaluate the effect of a modifier gene (MBL2) on variation in cystic fibrosis.

McDougal KE, Green DM, Vanscoy LL, Fallin MD, Grow M, Cheng S, Blackman SM, Collaco JM, Henderson LB, Naughton K, Cutting GR.

Eur J Hum Genet. 2010 Jun;18(6):680-4. doi: 10.1038/ejhg.2009.226. Epub 2010 Jan 13.

5.

Study of the effect of DNA polymorphisms in the mannose-binding lectin gene (MBL2) on disease severity in Slovak cystic fibrosis patients.

Tarova ET, Polakova H, Kayserova H, Celec P, Zuzulova M, Kadasi L.

Gen Physiol Biophys. 2011 Dec;30(4):373-8. doi: 10.4149/gpb_2011_04_373.

PMID:
22131319
6.

Polymorphisms in the lectin pathway genes as a possible cause of early chronic Pseudomonas aeruginosa colonization in cystic fibrosis patients.

Haerynck F, Van Steen K, Cattaert T, Loeys B, Van Daele S, Schelstraete P, Claes K, Van Thielen M, De Canck I, Mahachie John JM, De Baets F.

Hum Immunol. 2012 Nov;73(11):1175-83. doi: 10.1016/j.humimm.2012.08.010. Epub 2012 Aug 29.

PMID:
22940091
7.

Variants in mannose-binding lectin and tumour necrosis factor alpha affect survival in cystic fibrosis.

Buranawuti K, Boyle MP, Cheng S, Steiner LL, McDougal K, Fallin MD, Merlo C, Zeitlin PL, Rosenstein BJ, Mogayzel PJ Jr, Wang X, Cutting GR.

J Med Genet. 2007 Mar;44(3):209-14. Epub 2006 Dec 11.

8.

Genetic modifiers of liver disease in cystic fibrosis.

Bartlett JR, Friedman KJ, Ling SC, Pace RG, Bell SC, Bourke B, Castaldo G, Castellani C, Cipolli M, Colombo C, Colombo JL, Debray D, Fernandez A, Lacaille F, Macek M Jr, Rowland M, Salvatore F, Taylor CJ, Wainwright C, Wilschanski M, Zemková D, Hannah WB, Phillips MJ, Corey M, Zielenski J, Dorfman R, Wang Y, Zou F, Silverman LM, Drumm ML, Wright FA, Lange EM, Durie PR, Knowles MR; Gene Modifier Study Group.

JAMA. 2009 Sep 9;302(10):1076-83. doi: 10.1001/jama.2009.1295.

9.

Gene modifiers in cystic fibrosis.

Accurso FJ, Sontag MK.

J Clin Invest. 2008 Mar;118(3):839-41. doi: 10.1172/JCI35138.

10.

MBL2 polymorphisms screening in a regional Italian CF Center.

Trevisiol C, Boniotto M, Giglio L, Poli F, Morgutti M, Crovella S.

J Cyst Fibros. 2005 Sep;4(3):189-91.

11.

Interaction between a novel TGFB1 haplotype and CFTR genotype is associated with improved lung function in cystic fibrosis.

Bremer LA, Blackman SM, Vanscoy LL, McDougal KE, Bowers A, Naughton KM, Cutler DJ, Cutting GR.

Hum Mol Genet. 2008 Jul 15;17(14):2228-37. doi: 10.1093/hmg/ddn123. Epub 2008 Apr 17.

12.

Modulatory effect of the SLC9A3 gene on susceptibility to infections and pulmonary function in children with cystic fibrosis.

Dorfman R, Taylor C, Lin F, Sun L, Sandford A, Paré P, Berthiaume Y, Corey M, Durie P, Zielenski J; Members of Canadian Consortium for CF Genetic Studies.

Pediatr Pulmonol. 2011 Apr;46(4):385-92. doi: 10.1002/ppul.21372. Epub 2010 Oct 21.

PMID:
20967843
13.

Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy.

Harris WT, Muhlebach MS, Oster RA, Knowles MR, Clancy JP, Noah TL.

Pediatr Pulmonol. 2011 Jul;46(7):688-95. doi: 10.1002/ppul.21430. Epub 2011 Feb 18.

14.

Early childhood lung function is a stronger predictor of adolescent lung function in cystic fibrosis than early Pseudomonas aeruginosa infection.

Pittman JE, Noah H, Calloway HE, Davis SD, Leigh MW, Drumm M, Sagel SD, Accurso FJ, Knowles MR, Sontag MK.

PLoS One. 2017 May 15;12(5):e0177215. doi: 10.1371/journal.pone.0177215. eCollection 2017.

15.

Mannose-binding lectin deficiency is associated with early onset of polyarticular juvenile rheumatoid arthritis: a cohort study.

Dolman KM, Brouwer N, Frakking FN, Flatø B, Tak PP, Kuijpers TW, Førre O, Smerdel-Ramoya A.

Arthritis Res Ther. 2008;10(2):R32. doi: 10.1186/ar2386. Epub 2008 Mar 11.

16.

Update on gene modifiers in cystic fibrosis.

Collaco JM, Cutting GR.

Curr Opin Pulm Med. 2008 Nov;14(6):559-66. doi: 10.1097/MCP.0b013e3283121cdc. Review.

17.

Impact of mannose-binding lectin insufficiency on the course of cystic fibrosis: A review and meta-analysis.

Chalmers JD, Fleming GB, Hill AT, Kilpatrick DC.

Glycobiology. 2011 Mar;21(3):271-82. doi: 10.1093/glycob/cwq161. Epub 2010 Nov 2. Review.

PMID:
21045008
18.

Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease.

Collaco JM, Vanscoy L, Bremer L, McDougal K, Blackman SM, Bowers A, Naughton K, Jennings J, Ellen J, Cutting GR.

JAMA. 2008 Jan 30;299(4):417-24. doi: 10.1001/jama.299.4.417.

19.

Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection.

Park JE, Yung R, Stefanowicz D, Shumansky K, Akhabir L, Durie PR, Corey M, Zielenski J, Dorfman R, Daley D, Sandford AJ.

Genes Immun. 2011 Jul;12(5):370-7. doi: 10.1038/gene.2011.5. Epub 2011 Jan 27.

PMID:
21270830
20.

Supplemental Content

Support Center